Synopsis:

IHH Healthcare finally resolved its long-running dispute with Daiichi Sankyo over Fortis control, clearing SEBI’s approval and enabling a full open offer closure in November 2025.

A leading healthcare company known for robust financial performance and strong promoter backing is making headlines after reporting a 70% year-on-year profit growth in the latest quarter. In this new we will explores the company’s recent financial results, market movement, and the impact of a major stake acquisition that could shape its future trajectory.

Fortis Healthcare Limited ‘s stock, with a market capitalisation of Rs. 73,147 crores, fell to Rs. 949.60, hitting a low of up to 3.78 percent from its previous closing price of Rs. 986.90. Furthermore, the stock over the past year has given a ret

See Full Page